1 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 10 of 450 | 1580 prescriptions Less than 1% of all prescriptions | | 340 patients 10% of all patients | < 11 | |
2 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 20 of 830 | 1440 prescriptions Less than 1% of all prescriptions | 1180 | 380 patients 11% of all patients | < 11 | |
3 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 40 of 710 | 1290 prescriptions Less than 1% of all prescriptions | 1170 | 420 patients 13% of all patients | < 11 | |
4 PREDNISONE | 90 of 2860 | 1570 prescriptions Less than 1% of all prescriptions | 1300 | 800 patients 24% of all patients | 680 patients 21% of all patients | |
5 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 10 of 110 | 840 prescriptions Less than 1% of all prescriptions | 690 | 220 patients 7% of all patients | < 11 | |
6 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 10 of 50 | 930 prescriptions Less than 1% of all prescriptions | | 260 patients 8% of all patients | < 11 | |
7 IPRATROPIUM BROMIDE | 10 of 320 | 930 prescriptions Less than 1% of all prescriptions | | 440 patients 13% of all patients | < 11 | |
8 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 10 of 270 | 740 prescriptions Less than 1% of all prescriptions | 520 | 160 patients 5% of all patients | < 11 | |
9 MONTELUKAST SODIUM | 140 of 1820 | 640 prescriptions Less than 1% of all prescriptions | 280 | 150 patients 5% of all patients | < 11 | |
10 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 110 of 1270 | 520 prescriptions Less than 1% of all prescriptions | | 180 patients 5% of all patients | < 11 | |
11 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 10 of 90 | 800 prescriptions Less than 1% of all prescriptions | | 210 patients 6% of all patients | < 11 | |
12 PROAIR HFA (ALBUTEROL SULFATE) | 140 of 1730 | 560 prescriptions Less than 1% of all prescriptions | | 260 patients 8% of all patients | < 11 | |
13 AZITHROMYCIN | 110 of 1570 | 590 prescriptions Less than 1% of all prescriptions | | 260 patients 8% of all patients | < 11 | A |
14 FUROSEMIDE | 1430 of 2860 | 270 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 ESBRIET (PIRFENIDONE) | 10 | 440 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 10 of 20 | 310 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 510 of 1910 | 320 prescriptions Less than 1% of all prescriptions | 320 | < 11 | < 11 | |
18 SPIRIVA (TIOTROPIUM BROMIDE) | 380 of 1160 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 VENTOLIN HFA (ALBUTEROL SULFATE) | 500 of 2120 | 410 prescriptions Less than 1% of all prescriptions | | 180 patients 5% of all patients | < 11 | |
20 SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE/TRIMETHOPRIM) | 250 of 1110 | 200 prescriptions Less than 1% of all prescriptions | | 130 patients 4% of all patients | < 11 | A |
21 OFEV (NINTEDANIB ESYLATE) | 10 | 230 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 BEVESPI AEROSPHERE (GLYCOPYRROLATE/FORMOTEROL FUM) | 20 of 20 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
23 DULERA (MOMETASONE/FORMOTEROL) | 20 of 20 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 FLOVENT HFA (FLUTICASONE PROPIONATE) | 200 of 830 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 FLUTICASONE PROPIONATE | 690 of 1980 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 AMITRIPTYLINE HCL | 440 of 1510 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
27 DOXYCYCLINE HYCLATE | 80 of 1120 | 500 prescriptions Less than 1% of all prescriptions | | 410 patients 12% of all patients | < 11 | A |
28 PRADAXA (DABIGATRAN ETEXILATE MESYLATE) | 180 of 320 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
29 LORAZEPAM | 900 of 1960 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
30 LEVOFLOXACIN | 80 of 560 | 260 prescriptions Less than 1% of all prescriptions | | 220 patients 7% of all patients | < 11 | A |